Premium
Novel BAFF‐R CAR T‐cell Therapy for CD19 Antigen‐loss Relapsed B Cell Tumors
Author(s) -
Kwak L.W.,
Qin H.,
Dong Z.,
Wang X.,
Cheng W.A.,
Smith D.,
Song J.Y.,
Aldoss I.,
Muschen M.,
Forman S.J.
Publication year - 2019
Publication title -
hematological oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 44
eISSN - 1099-1069
pISSN - 0278-0232
DOI - 10.1002/hon.123_2629
Subject(s) - b cell activating factor , cd19 , chimeric antigen receptor , b cell , cancer research , antigen , medicine , immunology , t cell , antibody , immune system
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom